Literature DB >> 11256096

[Delay in the diagnosis of cancer].

M Bernal Pérez, F J Gómez Bernal, G J Gómez Bernal.   

Abstract

OBJECTIVE: A reduction in the time used to be able to diagnose an illness influences not only the well being of the patient but also the quality of the medical care. In this work, we have studied the amount of time needed to diagnose cancer. MATERIAL AND
METHOD: Descriptive methods have been used: average, median, mode and standard deviation in order to know how long it takes to diagnose and treat cancer. The data have been taken from a hospital register.
RESULTS: The longest time elapsed between the periods appears to be the one between the first symptoms and the date the diagnosis is made, which has been calculated to be 96 days on average. The remaining time periods studied showed a time lapse of about 26 days on median. DISCUSSION: The median has been taken as the measurement chosen to assess these time periods, which have been notably reduced in the last decade.
CONCLUSIONS: The performance of the primary care doctor is of great importance, as he is normally the one who is faced with the precocious symptoms, as well as with the risk factors that persist in the patients. This doctor is therefore the one who can initiate both the early diagnosis and the medical education of the patients.

Entities:  

Mesh:

Year:  2001        PMID: 11256096     DOI: 10.1016/s0212-6567(01)78778-1

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  5 in total

1.  Diagnosis delay and follow-up strategies in colorectal cancer. Prognosis implications: a study protocol.

Authors:  Salvador Pita Fernández; Sonia Pértega Díaz; Beatriz López Calviño; Paloma González Santamaría; Teresa Seoane Pillado; Francisco Arnal Monreal; Francesc Maciá; María Antonia Sánchez Calavera; Alejandro Espí Macías; Manuel Valladares Ayerbes; Alejandro Pazos; Margarita Reboredo López; Luis González Saez; María Ramos Montserrat; Josep María Segura Noguera; Isabel Monreal Aliaga; Luis González Luján; María Martín Rabadán; Cristiane Murta Nascimento; Olga Pueyo; Marta Maia Boscá Watts; Elena Cabeza Irigoyen; Montserrat Casmitjana Abella; Marina Pinilla; Ana Costa Alcaraz; Amador Ruiz Torrejón; Andrea Burón Pust; Concepción García Aranda; María de Lluc Bennasar; Sergio Lafita Mainz; Maite Novella; Hermini Manzano; Catalina Vadell; Esther Falcó; Magdalena Esteva
Journal:  BMC Cancer       Date:  2010-10-05       Impact factor: 4.430

2.  [Survival of patients diagnosed with prostate cancer and monitored in primary care].

Authors:  Gabriel J Díaz Grávalos; Gerardo Palmeiro Fernández; Inmaculada Casado Górriz; Margarita Arandia García; Susana Alvarez Araújo; Mónica González Dacosta
Journal:  Aten Primaria       Date:  2007-11       Impact factor: 1.137

3.  [Family practice and diagnosis of cancer].

Authors:  A Ruiz-Torrejón; M Ramos-Monserrat; J Llobera-Cánaves
Journal:  Aten Primaria       Date:  2006-01       Impact factor: 1.137

4.  Evaluation of unexplained peripheral lymphadenopathy and suspected malignancy using a distinct quick diagnostic delivery model: prospective study of 372 patients.

Authors:  Xavier Bosch; Emmanuel Coloma; Carolina Donate; Lluís Colomo; Pamela Doti; Anna Jordán; Alfonso López-Soto
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

5.  Factors Associated with Prolonged Patient-Attributable Delay in the Diagnosis of Colorectal Cancer.

Authors:  Irene Zarcos-Pedrinaci; Teresa Téllez; Francisco Rivas-Ruiz; María Del Carmen Padilla-Ruiz; Julia Alcaide; Antonio Rueda; María Luisa Baré; María Manuela Morales Suárez-Varela; Eduardo Briones; Cristina Sarasqueta; Nerea Fernández-Larrea; Antonio Escobar; José María Quintana; Maximino Redondo
Journal:  Cancer Res Treat       Date:  2018-01-02       Impact factor: 4.679

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.